TG THERAPEUTICS INC (TGTX)

US88322Q1085 - Common Stock

13.47  -0.44 (-3.16%)

After market: 13.57 +0.1 (+0.74%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
6.69M
4,360.00%		2.79M
-58.30%		233.662M
8,274.98%		269.13M
15.18%
EBITDA
YoY % growth
-344.49M
-25.99%		-192.54M
44.11%		20.844M
110.83%		-5.556M
-126.65%		N/AN/AN/AN/A
EBIT
YoY % growth
-344.77M
-26.02%		-192.84M
44.07%		20.633M
110.70%		-15.308M
-174.19%
Operating Margin
-5,153.51%-6,911.83%8.83%-5.69%
EPS
YoY % growth
-2.63
-15.86%		-1.46
44.49%		0.01
100.68%		-0.11
-1,222.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.04
86.99%
Revenue
Q2Q % growth		55.671M
613.73%
EBITDA
Q2Q % growth
EBIT
Q2Q % growth		-5.549M
85.00%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.10
74.36%		-0.110.015.99%
Q3 2023
Q2Q % growth		 0.73
380.77%		0.120.61518.52%
Q2 2023
Q2Q % growth		 -0.34
-13.33%		-0.25-0.09-34.00%
Q1 2023
Q2Q % growth		 -0.28
45.10%		-0.370.0925.23%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 43.971M
43,871.00%		40.865M3.106M7.60%
Q3 2023
Q2Q % growth		 165.8M
165,700.00%		47.492M118.308M249.11%
Q2 2023
Q2Q % growth		 16.1M
2,583.33%		17.802M-1.702M-9.56%
Q1 2023
Q2Q % growth		 7.8M
290.00%		3.447M4.353M126.28%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 68.95% 0% -1200%
Revenue0% 16.49% 0% 5.58%